As of June 21, 2025, Parallax Health Sciences Inc (PRLX) reports a Current Ratio of 0.01.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Parallax Health Sciences Inc's Current Ratio
Over recent years, Parallax Health Sciences Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2019-12-31 | 0.01 |
| 2018-12-31 | 0.00 |
| 2017-12-31 | 0.02 |
| 2016-12-31 | 0.32 |
| 2015-12-31 | 1.28 |
This slight downward trend highlights how Parallax Health Sciences Inc manages its short-term assets and liabilities over time.
Comparing Parallax Health Sciences Inc's Current Ratio to Peers
To better understand Parallax Health Sciences Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Parallax Health Sciences Inc (PRLX) | 0.01 |
| ICAD Inc (ICAD) | 3.50 |
| Vocera Communications Inc (VCRA) | 2.68 |
| Vigil Health Solutions Inc (VGL.V) | 2.56 |
| Cytta Corp (CYCA) | 2.04 |
| HTG Molecular Diagnostics Inc (HTGM) | 1.89 |
Compared to its competitors, Parallax Health Sciences Inc's Current Ratio is among the lowest compared to peers, suggesting tighter liquidity management or potential short-term obligations concerns.